Thomas Malinka

Dr. Thomas Malinka

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2016 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
GLGiulio Loforese
Giulio Loforese
TMThomas Malinka
Thomas Malinka
AKAdrian Keogh
Adrian Keogh
FBFelix Baier
Felix Baier
CSCedric Simillion
Cedric Simillion
DSDeborah Stroka
Deborah Stroka
The liver has an intrinsic capacity to regenerate in response to injury or surgical resection. Nevertheless, circumstances in which hepatocytes are unresponsive to proliferative signals result in impaired regeneration and hepatic failure. As the Hippo pathway has a canonical role in the maintenance of liver size, we investigated whether it could serve as a therapeutic target to support regeneration. Using a standard two‐thirds partial hepatectomy (PH) model in young and aged mice, we demonstrate that the Hippo pathway is modulated across the phases of liver regeneration. The activity of the core kinases MST1 and LATS1 increased during the early hypertrophic phase and returned to steady state levels in the proliferative phase, coinciding with activation of YAP1 target genes and hepatocyte proliferation. Moreover, following PH in aged mice, we demonstrate that Hippo signaling is anomalous in non‐regenerating livers. We provide pre‐clinical evidence that silencing the Hippo core kinases MST1 and MST2 with siRNA provokes hepatocyte proliferation in quiescent livers and rescues liver regeneration in aged mice following PH. Our data suggest that targeting the Hippo core kinases MST1/2 has therapeutic potential to improve regeneration in non‐regenerative disorders. ![][1] Inhibition of the Hippo core kinases MST1 and MST2 with siRNA has the therapeutic potential to improve liver regeneration in age‐related non‐regenerative disorders. [1]: /embed/graphic-1.gif

16 February 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LLLutz E Lehmann
Lutz E Lehmann
SHStefan Hauser
Stefan Hauser
TMThomas Malinka
Thomas Malinka
SKSven Klaschik
Sven Klaschik
SWStefan U Weber
Stefan U Weber
MBMalte Book
Malte Book
Urinary tract infections (UTI) are frequent in outpatients. Fast pathogen identification is mandatory for shortening the time of discomfort and preventing serious complications. Urine culture needs up to 48 hours until pathogen identification. Consequently, the initial antibiotic regimen is empirical. To evaluate the feasibility of qualitative urine pathogen identification by a commercially available real-time PCR blood pathogen test (SeptiFast®) and to compare the results with dipslide and microbiological culture. Pilot study with prospectively collected urine samples. University hospital. 82 prospectively collected urine samples from 81 patients with suspected UTI were included. Dipslide urine culture was followed by microbiological pathogen identification in dipslide positive samples. In parallel, qualitative DNA based pathogen identification (SeptiFast®) was performed in all samples. 61 samples were SeptiFast® positive, whereas 67 samples were dipslide culture positive. The inter-methodological concordance of positive and negative findings in the gram+, gram- and fungi sector was 371/410 (90%), 477/492 (97%) and 238/246 (97%), respectively. Sensitivity and specificity of the SeptiFast® test for the detection of an infection was 0.82 and 0.60, respectively. SeptiFast® pathogen identifications were available at least 43 hours prior to culture results. The SeptiFast® platform identified bacterial DNA in urine specimens considerably faster compared to conventional culture. For UTI diagnosis sensitivity and specificity is limited by its present qualitative setup which does not allow pathogen quantification. Future quantitative assays may hold promise for PCR based UTI pathogen identification as a supplementation of conventional culture methods.

18 March 2016 in EMBO Reports
Verified
Journal Article
Open access
PDF file
NLNatalia Lugli
Natalia Lugli
IKIrene Kamileri
Irene Kamileri
AKAdrian Keogh
Adrian Keogh
TMThomas Malinka
Thomas Malinka
MSMichalis E Sarris
Michalis E Sarris
THThanos D Halazonetis
Thanos D Halazonetis
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

8 February 2016 in Hepatology
Verified
Journal Article
Open access
PDF file
RKRamesh Kudira
Ramesh Kudira
TMThomas Malinka
Thomas Malinka
AKAndreas Kohler
Andreas Kohler
MDMichel Ernest Jean-Pierre Dosch
Michel Ernest Jean-Pierre Dosch
MAMercedes Gomez de Agüero
Mercedes Gomez de Agüero
GBGuido Beldi
Guido Beldi
Paracrine signalling mediated by cytokine secretion is essential for liver regeneration after hepatic resection, yet the mechanisms of cellular crosstalk between immune and parenchymal cells are still elusive. Interleukin‐22 (IL‐22) is released by immune cells and mediates strong hepatoprotective functions. However, it remains unclear whether IL‐22 is critical for the crosstalk between liver lymphocytes and parenchymal cells during liver regeneration after partial hepatectomy (PH). Here, we found that plasma levels of IL‐22 and its upstream cytokine, IL‐23, are highly elevated in patients after major liver resection. In a mouse model of PH, deletion of IL‐22 was associated with significantly delayed hepatocellular proliferation and an increase of hepatocellular injury and endoplasmic reticulum stress. UsingRag1−/−andRag2−/−γc−/−mice, we show that the main producers of IL‐22 post‐PH are conventional natural killer cells and innate lymphoid cells type 1. Extracellular adenosine triphosphate (ATP), a potent danger molecule, is elevated in patients immediately after major liver resection. Antagonism of the P2‐type nucleotide receptors, P2X1 and P2Y6, significantly decreased IL‐22 secretionex vivo.In vivo, specific inhibition of P2X1 was associated with decreased IL‐22 secretion, elevated liver injury, and impaired liver regeneration.Conclusion:This study shows that innate immune cell‐derived IL‐22 is required for efficient liver regeneration and that secretion of IL‐22 in the regenerating liver is modulated by the ATP receptor, P2X1. (Hepatology2016;63:2004‐2017)

7 June 2010 in BJU International
Verified
Journal Article
Closed access
PDF file
LLLutz E. Lehmann
Lutz E. Lehmann
SHStefan Hauser
Stefan Hauser
TMThomas Malinka
Thomas Malinka
SKSven Klaschik
Sven Klaschik
FSFrank Stüber
Frank Stüber
MBMalte Book
Malte Book

1 December 2018 in Surgical Oncology
Verified
Journal Article
Closed access
AAAndreas Andreou
Andreas Andreou
SKSebastian Knitter
Sebastian Knitter
FKFritz Klein
Fritz Klein
TMThomas Malinka
Thomas Malinka
MSMoritz Schmelzle
Moritz Schmelzle
MBMarcus Bahra
Marcus Bahra